Find clinical trials for Lymphoma in Berlin, BE
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Berlin, BE, DEU:
with Refractory/Relapsing (R/R) KIR3DL2 positive Peripheral T Cell Lymphoma (PTCL) : Not Other Specified (NOS), PTCL-TFH (including Angioimm...
Phase 2
Berlin, Germany and 63 other locations
The goal of this clinical trial is to study the addition of Acalabrutinib to standard R-miniCHOP in older adults with DLBCL. The main question it aim...
Phase 3
Berlin, Germany and 16 other locations
The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...
Phase 1, Phase 2
Berlin, Germany and 84 other locations
pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas...
Phase 1, Phase 2
Berlin, Germany and 36 other locations
in newly diagnosed elderly patients with Diffuse Large B-Cell Lymphoma (DLBCL) who cannot tolerate anthracycline therapy. Epcoritamab (also ...
Phase 2
Berlin, Germany and 74 other locations
with relapsed or refractory aggressive B-cell Non-Hodgkin's lymphoma. The study utilizes an optimized steroid premedication regimen and moni...
Phase 2
Berlin, Germany and 51 other locations
A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma...
Phase 2
Berlin, Germany and 174 other locations
a bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6), as a single agent and in combination with anti-lymphoma...
Phase 1, Phase 2
Berlin, Germany and 64 other locations
with relapsed/refractory (R/R) untreated CLL/small lymphocytic lymphoma (SLL). Adverse events, pharmacokinetics, and change in disease activ...
Phase 1
Berlin, Germany and 20 other locations
This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have previously received treatm...
Phase 3
Berlin, Germany and 233 other locations
Clinical trials
Research sites
Resources
Legal